Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

globenewswire

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target – NEWSnet – News… as it used to be

More Press Releases

May 2, 2026

Elektros Ignites a New Era of Profit in Energy: Breakthrough ‘Energy Core’ Platform Positions Investors to Capture Massive Upside Amid Historic Utility Cost Surge

May 2, 2026

NomosLogic Founder Matt Hardy Launches Lyceum and Odyssey on Dendrite Lite

May 2, 2026

How To Collect Unpaid Rent: Legal Compliance Tips For Property Managers

May 2, 2026

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

Elektros Ignites a New Era of Profit in Energy: Breakthrough ‘Energy Core’ Platform Positions Investors to Capture Massive Upside Amid Historic Utility Cost Surge

NomosLogic Founder Matt Hardy Launches Lyceum and Odyssey on Dendrite Lite

How To Collect Unpaid Rent: Legal Compliance Tips For Property Managers

Older Home Electrical Risks? Burlington ON Electricians Explain What to Know